The largest database of trusted experimental protocols

Stata mp version 16

Manufactured by StataCorp
Sourced in United States

Stata/MP version 16 is a high-performance statistical software package developed by StataCorp. It is designed to handle large and complex datasets, allowing users to perform advanced data analysis, statistical modeling, and visualization. Stata/MP is optimized for multi-core and multiprocessor systems, enabling faster computations and improved performance compared to the standard Stata software.

Automatically generated - may contain errors

112 protocols using stata mp version 16

1

Statistical Modeling in Scientific Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Generalised linear models were fitted with Stata/MP version 16 (StataCorp, TX). Bayesian spatial models were implemented in R version 4.0.3.
21 Incidence models were fitted with the CARBayes package (version 5.2.5)
22 while survival models were fitted with WinBUGS1.4.3
23 through the R2WinBUGS package (version 2.1‐21).
24 All other analyses were performed with Stata/MP version 16 (StataCorp, TX).
+ Open protocol
+ Expand
2

Vitamin D Deficiency and Adverse Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data were encoded in MS Excel and Stata MP version 16 software was used for data processing and analysis. Continuous variables were presented as mean (standard deviation/SD) or median (interquartile range/IQR) depending on the data distribution. Categorical variables were presented as frequencies and percentages. One-way ANOVA or Kruskal Wallis test was performed to compare continuous variables. Significant Kruskal Wallis test was further analyzed using Dunn’s test. Chi-square test or Fisher’s exact test was used to analyze categorical variables.
In order to determine the association between Vitamin D level and composite poor outcome, logistic regression analysis with Firth’s bias correction was done. Screening for potential confounders was performed using simple logistic regression analysis and a cutoff of p<0.2012 (link) (Supplemental Table A). Model building was performed using multiple logistic regression analysis and significant confounders were retained in the model using the change-in-estimate criterion of 10%. Imputation for missing data was not performed. P ≤0.05 were considered statistically significant.
+ Open protocol
+ Expand
3

Trends in Invasive Pneumococcal Disease in Elderly

Check if the same lab product or an alternative is used in the 5 most similar protocols
We computed the annual incidence rate of IPD in the elderly, overall, by vaccine-associated serotypes, and for all serotypes, for each country, between 2010 and 2019. Incidence rates were calculated per 100,000 people. The vaccine serotypes included in the analyses were PCV10, PCV13, PCV15, PCV20 and PPV23.
A linear regression model was used to estimate the average annual percentage change between 2010 to 2019 in the total IPD incidence rate in the elderly as well as for individual vaccine-serotypes, in each country. Associated 95% confidence intervals (CIs) and p-values were generated.
All statistical analyses were performed using STATA MP version 16 (StataCorp, College Station, TX).
+ Open protocol
+ Expand
4

Statistical Analyses of Oncology Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses were tabulated and analyzed by Stata/MP version 16. The Chi-square test was used to evaluate the association between categorical variables and the Mann–Whitney U test was applied to compare the continuous variables. The Kaplan–Meier method with log-rank test and Cox proportional hazard models were utilized to compare progression–free survival duration among the patient groups. The logistic regression models were used to compare PSA and radiological response among the patient groups. All the above models were based on the patients with available information on outcomes, such as progression-free survival duration (N = 192), PSA response (N = 146), and radiological response (N = 131). The factors with statistical significance (p < 0.1 in univariable analysis) were selected for the multivariable model. All tests were two-sided with p < 0.05 considered statistically significant. The missing value would not be included in the Cox proportional analysis.
+ Open protocol
+ Expand
5

Prevalence and Factors of Convincing Food Allergy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed from September 1, 2022, through April 10, 2023. Self-reported confirmed and convincing FA prevalence estimates were calculated using complex survey weighted proportions.1 (link),2 (link) Pearson χ2 statistics were calculated to test the independence of key study variables. Covariate-adjusted, complex survey-weighted logistic regression models compared relative prevalence and other convincing FA outcomes by participant characteristics, including interaction terms to assess moderation effects by demographic information. Two-sided hypothesis tests were used, and conventional thresholds of P < .05 denoted statistical significance. Stata MP, version 16 (StataCorp LLC), was used for all analyses.
+ Open protocol
+ Expand
6

Wastewater Microbial Characteristics and Correlations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microbiological characteristics were assessed both on an isolate-level and a collapsed wastewater sample-level. Respective differences in distributions were calculated using Chi-squared, Fisher’s exact, and Wilcoxon rank sum/Kruskal-Wallis tests—as appropriate. Missing data is indicated throughout. Correlation analyses of sample, socio-economic and meteorological parameters were performed using the Spearman’s rank correlation coefficients (rho) ranging from −1 to 1. Meteorological data were standardized across time and merged on a day-level for Basel overall. Socio-economic/population characteristics data were collapsed on a district-year level (medians) by weighting, where appropriate, for population size. Correlation strengths (rho) were defined as no correlation (0), very weak (0.01–0.19), weak (0.20–0.39), moderate (0.40–0.59), strong (0.60–0.79), and very strong (0.80–1.00). To visualize the strength of the relationships between the different variables, the matrix information were plotted using heatmaps (Stata packages “heatplot” (Jann, 2019 ), “palettes” and “colrspace”). Intracluster correlation was marginal overall and was therefore not considered in the explorative hypothesis tests. All analyses were performed on a multicore system with Stata/MP version 16 (Stata Corp., College Station, Texas, United States). All reported p-values are two-sided.
+ Open protocol
+ Expand
7

Vitamin D Levels in Lupus Subtypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analysis was performed using STATA/MP version 16 (STATA Corp, College Station, TX). For continuous variables, normally distributed variables were summarized using the mean and SD, while the median and interquartile ranges were used for non-normally distributed variables. Univariate comparisons between categorical variables were performed using the Chi-square test or Fisher's exact test. We performed three independent groups comparison (SLE without CLE, SLE with CLE, and CLE-only). We used ANOVA to compare the difference among normally distributed variables. Meanwhile, non-normally distributed variables were analyzed by Kruskal–Wallis tests.
Multivariate analyses were performed by multiple linear regression models to identify independent factors of serum 25(OH)D level which allows adjustment for potential confounding factors (ie, age, gender, BMI, disease duration, lupus subgroup, SLEDAI-2K score, presence of LN, prednisolone dose, hydroxychloroquine (HCQ) intake, immunosuppressants administration, calcium, and vitamin D supplement). A p-value less than 0.05 was considered statistically significant.
+ Open protocol
+ Expand
8

Postoperative VTE Risk Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Since some patients might have undergone surgery with a previously unrecognized cancer, we did a supplementary analysis, by restriction of the study population to patients free from cancer at baseline. In this sub-cohort, we applied a time-dependent stratification on patients who did and did not develop cancer during follow-up. Furthermore, to clarify the short-term VTE risk after surgery, the VTE risk was also investigated within 7 days after surgery.
The following additional analyses were conducted: (1) VTE risk stratifying patients in age categories as suggested in the Caprini score [22 ] (< 41 years, 41–59 years, 60–74 years, > 74 years); and (2) VTE risks after surgery according to varying anatomic areas (surgeries related to mouth/throat, nose/sinuses, ear, and endoscopies, respectively).
Analyses were conducted using Stata/MP version 16 (StataCorp LP). This study was conducted in compliance with the General Data Protection Regulation and is part of North Denmark Region’s record of processing activities (j.no. 2017–68). Other approvals were not necessary according to Danish legislation.
+ Open protocol
+ Expand
9

Predictive Model Validation and Calibration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The final developed model equation was applied to the validation dataset, and calibration and discrimination were examined as above.44 (link),45 Calibration of 5-year risks was examined by plotting agreement between estimated risk from the model and observed outcome risks. Predicted and observed risks were divided into 10 equally sized groups. Additionally, pseudo-observations were used to construct smooth calibration curves across all individuals via a running non-parametric smoother. Separate calibration plots were provided for each imputation. Age-group, inflammatory disease type, and whether the patient was commenced on thiopurine after the year 2010, formed the basis of sub-group analyses. Stata-MP version 16 was used for all statistical analyses and data visualisation.
This study was reported in line with the transparent reporting of a multivariate prediction model for individual prediction or diagnosis (TRIPOD) guidelines.46 (link)
+ Open protocol
+ Expand
10

HSV-2 Meningitis Treatment Survey

Check if the same lab product or an alternative is used in the 5 most similar protocols
Binary variables are presented as n/N to account for missing values and percentages. Continuous variables are described as medians with interquartile ranges (IQRs). Response rates were estimated by division of respondents by the total number of ID specialists employed at each included hospital in Denmark and Sweden. For the French and Australian distribution networks, response rates were defined as number of respondents divided by total number of ID physicians (specialists and residents) in the research networks (approximately 700 in each country). A sensitivity analysis restricted to participants with complete responses was also performed. This was a descriptive survey of HSV-2 meningitis treatment, and a sample size calculation was not meaningful for this type of study. Stata MP version 16 (StataCorp, College Station, Texas) was used for all statistical analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!